Mayne Pharma Group Limited (MYX.AX)

AUD 6.98

(-0.29%)

Eps Summary of Mayne Pharma Group Limited

Mayne Pharma Group Limited's latest annual eps in 2024 was -2.19 AUD , up 43.7% from previous year.
Mayne Pharma Group Limited's latest quarterly eps in 2024 FY was N/A , up 43.7% from previous quarter.
Mayne Pharma Group Limited reported an annual eps of -3.89 AUD in 2023, down -12.43% from previous year.
Mayne Pharma Group Limited reported an annual eps of -3.46 AUD in 2022, down -34.63% from previous year.
Mayne Pharma Group Limited reported a quarterly eps of -0.87 AUD for 2024 Q2, down 0.0% from previous quarter.
Mayne Pharma Group Limited reported a quarterly eps of N/A for 2024 FY, up 43.7% from previous quarter.

Annual Eps Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Eps of Mayne Pharma Group Limited (2024 - 2007)

Year	Eps	Eps Growth
2024	-2.19 AUD	43.7%
2023	-3.89 AUD	-12.43%
2022	-3.46 AUD	-34.63%
2021	-2.57 AUD	-125.44%
2020	-1.14 AUD	66.86%
2019	-3.44 AUD	-108.48%
2018	-1.65 AUD	-233.06%
2017	1.24 AUD	30.53%
2016	0.95 AUD	331.82%
2015	0.22 AUD	-68.12%
2014	0.69 AUD	2071.43%
2013	-0.04 AUD	-106.03%
2012	0.58 AUD	262.5%
2011	0.16 AUD	-57.89%
2010	0.38 AUD	920.73%
2009	-0.05 AUD	-8.43%
2008	-0.04 AUD	-89.78%
2007	-0.02 AUD	0.0%

Year	Eps	Eps Growth
2024 Q4	-1.25 AUD	0.0%
2024 Q2	-0.87 AUD	0.0%
2024 FY	- AUD	43.7%
2023 FY	- AUD	-12.43%
2023 Q2	-1.64 AUD	0.0%
2023 Q4	-2.06 AUD	0.0%
2022 Q2	-0.62 AUD	0.0%
2022 FY	- AUD	-34.63%
2022 Q4	-2.41 AUD	0.0%
2021 Q2	-2.32 AUD	0.0%
2021 Q4	-0.31 AUD	0.0%
2021 FY	- AUD	-125.44%
2020 FY	- AUD	66.86%
2020 Q2	-0.23 AUD	0.0%
2020 Q4	-0.90 AUD	0.0%
2019 Q4	-3.43 AUD	0.0%
2019 FY	- AUD	-108.48%
2019 Q2	0.04 AUD	0.0%
2018 Q2	-2.38 AUD	0.0%
2018 FY	- AUD	-233.06%
2018 Q4	0.55 AUD	0.0%
2017 Q2	1.01 AUD	0.0%
2017 Q4	0.21 AUD	0.0%
2017 FY	- AUD	30.53%
2016 FY	- AUD	331.82%
2016 Q4	0.45 AUD	0.0%
2016 Q2	0.48 AUD	0.0%
2015 Q4	0.10 AUD	0.0%
2015 Q2	0.13 AUD	0.0%
2015 FY	- AUD	-68.12%
2014 Q2	0.29 AUD	0.0%
2014 FY	- AUD	2071.43%
2014 Q4	0.43 AUD	0.0%
2013 Q4	-0.01 AUD	-10600.0%
2013 Q3	-0.00 AUD	99.95%
2013 Q2	-0.20 AUD	0.0%
2013 FY	- AUD	-106.03%
2012 Q2	0.02 AUD	18800.0%
2012 Q3	0.00 AUD	-97.88%
2012 Q4	0.02 AUD	4625.0%
2012 FY	- AUD	262.5%
2012 Q1	0.00 AUD	-98.08%
2011 Q4	0.01 AUD	5100.0%
2011 FY	- AUD	-57.89%
2011 Q3	0.00 AUD	-98.08%
2011 Q2	0.01 AUD	2500.0%
2011 Q1	0.00 AUD	-98.0%
2010 Q3	0.00 AUD	-98.0%
2010 Q4	0.01 AUD	4900.0%
2010 Q1	-0.00 AUD	96.55%
2010 Q2	0.01 AUD	2600.0%
2010 FY	- AUD	920.73%
2009 Q3	-0.00 AUD	96.55%
2009 Q2	-0.01 AUD	-2800.0%
2009 Q1	-0.00 AUD	96.26%
2009 Q4	-0.01 AUD	-2800.0%
2009 FY	- AUD	-8.43%
2008 Q1	-0.00 AUD	92.86%
2008 Q4	-0.01 AUD	-2575.0%
2008 Q2	-0.01 AUD	-2575.0%
2008 Q3	-0.00 AUD	96.26%
2008 FY	- AUD	-89.78%
2007 FY	- AUD	0.0%
2007 Q4	-0.01 AUD	-1300.0%
2007 Q3	-0.00 AUD	92.86%
2007 Q2	-0.01 AUD	0.0%

Peer Eps Comparison of Mayne Pharma Group Limited

Name	Eps	Eps Difference
Firebrick Pharma Limited	-0.01 AUD	-33081.818%